MedTrace Logo

Clinical Validation of Biofinity Toric MTO (Made To Order) Lenses

NCT02185105 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-03-07

Study results available
· View outcomes & findings →

Summary

The study hypothesis is there is no difference in the clinical performance between the test and control lenses, in particular in lens stability, toric mislocation, comfort ratings and anterior segment ocular health findings.

Conditions

  • Myopia
  • Astigmatism

Interventions

DEVICE

comfilcon A MTO

Randomized to a test lens in one eye and control lens in the other as a matched pair.

DEVICE

comfilcon A

Randomized to a test lens in one eye and control lens in the other as a matched pair.

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Pete S Kollbaum, O.D. · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02185105 on ClinicalTrials.gov